Download presentation
Presentation is loading. Please wait.
Published byLaureen Terry Modified over 9 years ago
1
Biology and Control of Giardia and Cryptosporidium Miodrag Belosevic, PhD, FRS(TMH), Department of Biological Sciences University of Alberta
2
Waterborne Protozoa Cryptosporidium Giardia Entamoeba Naegleria Toxoplasma Acanthamoeba
3
The Course of Protozoan Infections in Different Hosts Latent Period Acute Phase Elimination Phase
4
Characteristics of Infection low numbers of parasites required to initiate infection multiplication in the host- transmission self-limiting - except immundeficient individuals Zoonosis - cross-species transmission
5
Cryptosporidium: Public Health Significance Worldwide prevalence about 10% Zoonosis, human and animal genotypes Oocysts ubiquitous in surface waters Difficult to remove, and hard to kill Drinking water - amplifier for disease Up to 20% of general population may be considered at higher risk
6
Cryptosporidiosis: The Disease Serious disease in the young, pregnant women, patients undergoing chemotherapy and elderly Potentially fatal in immundeficient hosts Infectious dose in healthy humans is low: ID 50 about 130 oocysts No effective chemotherapy available
7
Giardia: The Organism obligate intestinal parasites of all classes of vertebrates more than 100 described species two stages in the life cycle: the motile trophozoites that inhabit the small intestine of the host, and the resistant cysts found in the environment
8
Giardiasis: Public Health Significance Worldwide prevalence about 8%, much higher in endemic areas Zoonosis Most prevalent in day care centers, mental institutions, male homosexuals Children, elderly and immunodeficient persons more susceptible Transmitted by direct contact, food or water Chemotherapy available- some drug resistance
9
Giardiasis: The Disease asymptomatic: largest group symptomatic: self-limiting infection, diarrhea, abdominal cramps,fever, nausea and weight loss symptomatic: chronic infection, immunodeficient individuals, malabsorption, food intolerance, chronic inflammation of the mucosa
10
Parasites in Water Detection in Environment Inactivation Efficacy Viability Assays Animal Infectivity
11
Measures of Viability ANIMAL INFECTIVITY: expensive, very reliable EXCYSTATION: not accurate- overestimates viability CELL CULTURE: underestimates viability, contamination NUCLEIC ACID DYES: inexpensive, convenient & rapid
12
Animal Infectivity Answers the public health question: will the organism cause an infection? Depends on the dose-response in susceptible animal hosts Complex, labor intensive, time- consuming
13
Infectivity Assay Infectivity in neonatal CD-1 mice Flow cytometry of lower half of intestine
14
Organisms are organic particles Sources in water supplies include: human wastes from point-sources uncontrolled non-point source pollution from agriculture and natural sources disposal/recycling of water treatment wastes View microbial reduction as a system of multiple processes designed to eliminate/inactivate infectious particles Modern Concept of Inactivation
15
Control of Protozoa In Drinking Water Multiple barrier approach: –Filtration –Chemical inactivation- ozone, combination of disinfectants –Medium-pressure ultraviolet light (UV) Monitoring: –Presence of protozoa in raw water –Viability assessment in finished water
16
Water quality dissolved organic carbon pH temperature turbidity Concentration of oxidant Contact time Factors Affecting Chemical Inactivation
17
From: C.N. Haas et al. 1996. Journal of the American Water Works Association, 88(9): 131-136. 0 1 2 3 4 5 0.010.11101001000 Overall oocyst treatment Influent oocysts (no./100 L) Inadequate protection Adequate protection Degree of Microbial Inactivation Required for 1:10,000 Annual Risk /Person
18
Health effects criteria: serum antibody surveys of communities parasitological survey of communities Quantitative risk assessment: concentration of parasite in source water assume annual per person risk level of 1:10,000 Microbial Reduction Goals
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.